Ładuje się......
Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?
Understanding the molecular defects underlying cardiovascular disease is necessary for the development of therapeutics. The most common method to lower circulating lipids, which reduces the incidence of cardiovascular disease, is statins, but other drugs are now entering the clinic, some of which ha...
Zapisane w:
| Wydane w: | Biochim Biophys Acta |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5953829/ https://ncbi.nlm.nih.gov/pubmed/29627384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbalip.2018.03.010 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|